期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY LetPub Score 9.1
50 ratings
Rate
Reputation 10.0 Influence 8.5 Speed 8.2 | ||||||||||||||||||||||||||||
期刊簡稱 | J AM SOC NEPHROL | ||||||||||||||||||||||||||||
ISSN | 1046-6673 | ||||||||||||||||||||||||||||
E-ISSN | 1533-3450 | ||||||||||||||||||||||||||||
h-index | 253 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 3.90%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://jasn.asnjournals.org/ | ||||||||||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/jasn | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | American Society of Nephrology | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||||||
每年文章數 | 143每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 5.43% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1046-6673%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-8 Week(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY] 的評論 | 撰寫評論 |
作者: 风啸以柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-23 10:33:16 評論於 How come the scores have dropped so much this year?(0) 讚! | 风啸以柳 |
作者: 邻家忆夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-06 17:03:13 評論於 The instructions of authors in the author resources have formatting requirements. Reviews should have the following elements in order: title page, abstract, integrated discussion, acknowledgments, disclosures, funding, references, figure legend, and figure(s) or table(s(0) 讚! | 邻家忆夏 |
作者: 邻家忆夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-27 12:35:55 評論於 It shouldn't be accepted(0) 讚! | 邻家忆夏 |
作者: 易筋含烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-10 17:33:37 評論於 Is there any specific format requirement for the submission of review articles? I didn't see any requirements for reviews on the official website(0) 讚! | 易筋含烟 |
作者: 雾都己酉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-15 09:58:36 評論於 Awesome!(0) 讚! | 雾都己酉 |
作者: 是你的艳蕾呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-08 20:45:06 評論於 This magazine requires signing a copyright agreement before even submitting the article. Shouldn't it be signed after acceptance?(0) 讚! | 是你的艳蕾呀 |
作者: 凌霄秋灵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-21 23:10:53 評論於 When registering for a JASN account, it prompts for a verification code, but the website does not display any verification. What should I do?(0) 讚! | 凌霄秋灵 |
作者: 凌霄秋灵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-09 21:17:52 評論於 Do we need a fluorescence curve for QPCR?(0) 讚! | 凌霄秋灵 |
作者: 岭南念真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-28 11:12:09 評論於 May I submit a case?(0) 讚! | 岭南念真 |
作者: 邻家忆夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-19 21:04:47 評論於 Please send the agreed manuscript to us, and we will usually decide whether to send it for review within a week. If your research group needs the article to be published urgently, we can even make the decision to send it for review on the next day(0) 讚! | 邻家忆夏 |
作者: 邻家忆夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-19 08:53:55 評論於 Agreeing to something generally means that you are interested in the topic. The likelihood is quite high, with the main determining factor being your writing level(0) 讚! | 邻家忆夏 |
作者: Gail Acheson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-07 12:35:40 評論於 Hello, I would like to inquire about how many days it will take for a manuscript to enter the "under review" stage with the editor. I have previously received an invitation to submit the paper and the editor agreed to consider it for publication. What are the chances of it being rejected in this scenario?(0) 讚! | Gail Acheson |
作者: suleyman 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-01-12 22:35:56 評論於 Translated text: "Reviewed a comprehensive review as a free submission. The first review was relatively fast, exactly one month. The questions raised by the reviewers significantly improved the quality of the manuscript. After making revisions for a month, it was resubmitted and accepted after more than 20 days."(0) 讚! | suleyman |
作者: 邻家忆夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-05 22:39:53 評論於 Review Speed: 1.0 | Submission Hit Rate: 50.0 | Page Fee: 2800.0 Experience Sharing: Successfully submitted a free-review overview article. The first review was quite fast, exactly one month. The questions raised by the reviewers helped to improve the quality of the manuscript. Returned for revision after one month, and accepted after more than 20 days(0) 讚! | 邻家忆夏 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:17:42 評論於 Currently ORCID is optional, not mandatory. It is important to note that most publishers (including Elsevier, Wiley, Nature, Thomson Reuters) now require all researchers associated with their publications to use an ORCID iD. If an article is published without providing an ORCID iD, how can it be added? ORCID stands for Open Researcher and Contributor ID. The ORCID iD is a unique and persistent academic identity for authors, distinguishing them from other researchers and recording all of their relevant research activities. It is necessary to log into each author's account, then link it in the account information modification section(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:29:58 評論於 ORCID is an open researcher and contributor identifier (Researcher and Contributor ID), and is a non-profit organization. The ORCID ID is a unique and persistent academic identity for authors, distinguishing them from other researchers and recording all their relevant research activities. Researcher can register for an ORCID ID for free at https://orcid.org/signin by providing their name, email, and setting a password(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 22:14:09 評論於 What is ORCID ID? How can I register?(0) 讚! | 八坂篷蔚 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 11:36:21 評論於 Is it necessary to provide the ORCID ID of each author when submitting a manuscript?(0) 讚! | 北国博达 |
作者: 采梦可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-15 11:43:47 評論於 Can WB strips be trimmed or must they be fully coated?(0) 讚! | 采梦可爱吗 |
作者: Oliver Jerry 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-25 10:12:35 評論於 Amazing, amazing(0) 讚! | Oliver Jerry |
作者: 北海初柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-10-12 19:46:47 評論於 One as the first author and one as the corresponding author were accepted by two journals. It was tough for me personally as the amount of data is large, and the reviewers raised very professional and challenging questions on the articles, pinpointing its weaknesses. The process of publishing these articles was long; it took more than a year for each to go online(0) 讚! | 北海初柳 |
作者: Anonymous 領域: 医药科学 審稿時間: 6.0 month(s) 結果: 修改後接受 撰寫評論 |
2016-08-19 11:03:41 評論於 It took a long time from submission, revisions, reception, and being published online to receiving a paper version. It is very hard to get accepted by this journal. (0) 讚! | Anonymous |
作者: 巴蜀景同 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-08-19 10:32:47 評論於 Review speed: 6.0 Experience sharing: Being the co-first author of a paper, it took almost half a year from submission, major revision, acceptance, online publication to receiving the hard copy. It was really tough(0) 讚! | 巴蜀景同 |
作者: Vincent Gracie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-25 21:56:05 評論於 It took nearly half a year from submitting, revising, being accepted, going online to receiving the print version for this shared first-authored paper, which was torturous(0) 讚! | Vincent Gracie |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-03-22 19:42:11 評論於 Review speed: 2.0 | Submission hit rate: 25.0 Experience sharing: The above is nonsense, nonsense(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us